Interaction between levothyroxine and indinavir in a patient with HIV infection

Infection

Volumn 30, Issue 1, 2002, Pages 54-55

  Sobngwi, E ^a,b   Mbanya, J C N ^a   Unwin, N C ^b,c   Kengne, A P ^a   Minkoulou, E M ^a   Fezeu, L ^a   Aspray, T J ^b,c   Alberti, K G M ^b  

^a University of Yaounde   (South Africa)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

HIV infection; Hyperthyroidism; Hypothyroidism; Indinavir; Levothyroxine

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; ANTIRETROVIRUS AGENT; CYTOCHROME P450; ETHINYLESTRADIOL; GLUCURONOSYLTRANSFERASE; INDINAVIR; LAMIVUDINE; LEVOTHYROXINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; GILBERT DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; HYPOTHYROIDISM;

ADULT; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; INDINAVIR; THYROXINE;

EID: 0036171953     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2092-3     Document Type: Article

References (10)

1. Interactions among drugs for HIV and opportunistic infections
2. Effect of ritonavir on the pharmacokinetics of ethinyl estradiol in healthy female volunteers
3. Nelfinavir mesylate: A protease inhibitor
4. Interaction between levothyroxine and ritonavir
5. In vitro and in vivo disposition and metabolism of 3′-deoxy-2′,3′didehydrothymidine
6. The safety pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: A phase I study
7. Single dose pharmacokinetics of indinavir and the effect of food
8. Metabolites of L-735, 524, a potent HIV 1-protease inhibitor, in human urine